Binding of d-threo-[11C]methylphenidate to the dopamine transporter in vivo: insensitivity to synaptic dopamine
Authors:
- 1 August 1995
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 281 (2) , 141-149
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Sensitivity of striatal [11C]cocaine binding to decreases in synaptic dopamineSynapse, 1995
- Pharmacokinetics and in vivo specificity of [LLC]dl‐threo‐methylphenidate for the presynaptic dopaminergic neuronSynapse, 1994
- Stereospecific Distribution of Methylphenidate Enantiomers in Rat Brain: Specific Binding to Dopamine Reuptake SitesPharmaceutical Research, 1994
- Positron emission tomographic imaging of the dopamine transporter with 11C‐WIN 35,428 reveals marked declines in mild Parkinson's diseaseAnnals of Neurology, 1993
- Striatal binding of the PET ligand 11C‐raclopride is altered by drugs that modify synaptic dopamine levelsSynapse, 1993
- GABAergic inhibition of endogenous dopamine release measured in vivo with 11C-raclopride and positron emission tomographyJournal of Neuroscience, 1992
- Vesicular accumulation of dopamine following L-DOPA administrationBiochemical Pharmacology, 1989
- Mapping cocaine binding sites in human and baboon brain in vivoSynapse, 1989
- Synthesis of [methoxy‐3H]‐ and [methoxy‐11C]‐ labelled raclopride. Specific dopamine‐D2 receptor ligandsJournal of Labelled Compounds and Radiopharmaceuticals, 1987
- The Use of Psychostimulants in General PsychiatryArchives of General Psychiatry, 1987